OOIR: Observatory of International Research

Papers

(The median citation count of Medical Oncology is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Cancer induced bone pain: current management and future perspectives	43
Cancer stem cell characteristics and their potential as therapeutic targets	42
Vaccination of cancer patients against COVID-19: towards the end of a dilemma	41
Effects of electroporation on anticancer activity of 5-FU and newly synthesized zinc(II) complex in chemotherapy-resistance human brain tumor cells	32
The CXCL12/CXCR7 signalling axis promotes proliferation and metastasis in cervical cancer	27
Correction to: The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma	26
Immune microenvironment-related gene mapping predicts immunochemotherapy response and prognosis in diffuse large B-cell lymphoma	25
Resistin increases cisplatin-induced cytotoxicity in lung adenocarcinoma A549 cells via a mitochondria-mediated pathway	22
The genomic architecture of metastasis in breast cancer: focus on mechanistic aspects, signalling pathways and therapeutic strategies	22
Metabolic shift of chronic myeloid leukemia patients under imatinib–pioglitazone regimen and discontinuation	21
Identification of the dominant angiogenic CXCL class chemokines associated with non-small cell lung cancer via bioinformatics tools	20
Identification of key genes in the tumor microenvironment of lung adenocarcinoma	19
Combination of resveratrol and BIBR1532 inhibits proliferation of colon cancer cells by repressing expression of LncRNAs	19
Computational study on novel natural inhibitors targeting BCL2	19
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in regard to Triggiani et al.	18
Upfront metastasis-directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance	17
Systematic identification of the cancer pathways and molecules related with breast cancer immunogenicity	17
Application of comprehensive bioinformatics approaches to reconnoiter crucial genes and pathways underpinning hepatocellular carcinoma: a drug repurposing endeavor	16
Investigation of the Osteopontin isoforms expression in patients with acute myeloid leukemia	16
Identification of potential genes associated with ALDH1A1 overexpression and cyclophosphamide resistance in chronic myelogenous leukemia using network analysis	15
Hypofractionated whole-breast radiotherapy in large breast size patients: is it really a resolved issue?	15
Hypofractionated breast irradiation: a multidisciplinary review of the Senonetwork study group	15
Upfront metastasis‑directed therapy in oligorecurrent prostate cancer does not decrease the time from initiation of androgen deprivation therapy to castration resistance: in response to Onal’s letter	15
Suppressed PLIN3 frequently occurs in prostate cancer, promoting docetaxel resistance via intensified autophagy, an event reversed by chloroquine	15
The role of the WNT signaling pathway in the maxillary sinus squamous cell carcinoma	13

A linkage between effectual genes in progression of CRC through canonical and non-canonical TGF-β signaling pathways	13
Comparative expression analysis of dasatinib and ponatinib-regulated lncRNAs in chronic myeloid leukemia and their network analysis	13
The anti-angiogenic agent lenvatinib induces tumor vessel normalization and enhances radiosensitivity in hepatocellular tumors	13
Impact of intravesical instillation of a novel biological response modifier (P-MAPA) on progress of non-muscle invasive bladder cancer treatment in a rat model	13
Oncotype DX testing does not affect clinical practice in stage IIa colon cancer	13
Correction to: Glioma cells escaped from cytotoxicity of temozolomide and vincristine by communicating with human astrocytes	13
In-vitro analysis on the potential use of dental pulp mesenchymal stem cells on arecoline-induced oral epithelial cells	13
PSMA: a game changer in the diagnosis and treatment of advanced prostate cancer	12
COVID-19 pandemic: a new cause of unplanned interruption of radiotherapy in breast cancer patients	12
CD44-positive cancer stem cells from oral squamous cell carcinoma exhibit reduced proliferation and stemness gene expression upon adipogenic induction	12
Overcoming resistance to targeted therapy using MET inhibitors in solid cancers: evidence from preclinical and clinical studies	12
Lipid droplet evolution gives insight into polyaneuploid cancer cell lipid droplet functions	12
Forward to a methodological proposal to support cancer patients: the dialogics’ contribution for the precision care	11
Molecular targets and therapeutics in chemoresistance of triple-negative breast cancer	11
Melittin, a honeybee venom derived peptide for the treatment of chemotherapy-induced peripheral neuropathy	11
How should we manage non-small-cell lung cancer “not-otherwise-specified”?	11
Employing bioinformatics analysis to identify hub genes and microRNAs involved in colorectal cancer	11
Attitudes, practices and perspectives on imaging strategies in prostate cancer: a national cross-sectional survey involving expert radiation oncologists on behalf of AIRO (Italian association of radio	11
Detection of human papillomavirus infection in oral cancers reported at dental facility: assessing the utility of FFPE tissues	11
Combined evaluation of proliferation and apoptosis to calculate IC50 of VPA-induced PANC-1 cells and assessing its effect on the Wnt signaling pathway	11
Who should be treated with pembrolizumab in addition to standard of care in advanced cervical cancer?	11
The combined therapy of miR-383-5p restoration and paclitaxel for treating MDA-MB-231 breast cancer	11
SNRPB is a mediator for cellular response to cisplatin in non-small-cell lung cancer	10
Transcription factors linked to the molecular signatures in the development of hepatocellular carcinoma on a cirrhotic background	10
Balstilimab and other immunotherapy for recurrent and metastatic cervical cancer	10
Novel therapeutic strategies and perspectives for pancreatic cancer: Autophagy and apoptosis are key mechanisms to fight pancreatic cancer	10
CDK9 inhibitors in multiple myeloma: a review of progress and perspectives	10
The role of inflammatory indices in the outcome of COVID-19 cancer patients	10
A prospective phase II clinical trial identifying the optimal regimen for carboplatin plus standard backbone of anthracycline and taxane-based chemotherapy in triple negative breast cancer	10
N-Myc promotes angiogenesis and therapeutic resistance of prostate cancer by TEM8	10
The immunomodulatory effects of Candida albicans isolated from the normal gastrointestinal microbiome of the elderly on colorectal cancer	10
PARP inhibitors: shifting the paradigm in the treatment of pancreatic cancer	9
The role of BAFF and G-CSF for rituximab-induced late-onset neutropenia (LON) in lymphomas	9
Correction to: Diosmetin induces apoptosis in ovarian cancer cells by activating reactive oxygen species and inhibiting the Nrf2 pathway	9
Triple-arm androgen blockade for advanced prostate cancer: a review	9
Submicron particle docetaxel intratumoral injection in combination with anti-mCTLA-4 into 4T1-Luc orthotopic implants reduces primary tumor and metastatic pulmonary lesions	9
How to ensure uninterrupted treatment of radiotherapy patients during delta variants of SARS-CoV-2 virus epidemic: the latest experience from Xi’an, China	8
Defining candidate mRNA and protein EV biomarkers to discriminate ccRCC and pRCC from non-malignant renal cells in vitro	8
Nicaraven prevents the fast growth of inflamed tumors by an anti-inflammatory mechanism	8
The effects of chemotherapeutic drugs on PD-L1 gene expression in breast cancer cell lines	8
Molecular profile to guide personalized medicine in adult patients with primary brain tumors: results from the ProfiLER trial	8
Bevacizumab in combination with paclitaxel and platinum for previously treated advanced thymic epithelial tumors	8
Bioinformatics analysis of C3 in brain low-grade gliomas as potential therapeutic target and promoting immune cell infiltration	8
Ambient air emissions of endocrine-disrupting metals and the incidence of hormone receptor- and HER2-dependent female breast cancer in USA	8
The effect of metformin when combined with neoadjuvant chemotherapy in breast cancer patients	8
RETRACTED ARTICLE: The function of Cav-1 in MDA-MB-231 breast cancer cell migration and invasion induced by ectopic ATP5B	8
The analysis of N6-methyladenosine regulators impacting the immune infiltration in clear cell renal cell carcinoma	8
Interferon regulatory factor-1 regulates cisplatin-induced apoptosis and autophagy in A549 lung cancer cells	8
Molecular analysis of cell survival and death pathways in the proteasome inhibitor bortezomib-resistant PC3 prostate cancer cell line	8
The effect of the COVID-19 pandemic on routine adult vaccination in cancer patients	7

Identification of cell cycle as the critical pathway modulated by exosome-derived microRNAs in gallbladder carcinoma	7
Treating MCF7 breast cancer cell with proteasome inhibitor Bortezomib restores apoptotic factors and sensitizes cell to Docetaxel	7
Impact of a combined integrative oncology and palliative care program on quality of life of patients with advanced cancer	7
Possible protective effect of pantoprazole against cisplatin-induced nephrotoxicity in head and neck cancer patients: a randomized controlled trial	7
Exosome application in tumorigenesis: diagnosis and treatment of melanoma	7
In silico bioinformatics analysis for identification of differentially expressed genes and therapeutic drug molecules in Glucocorticoid-resistant Multiple myeloma	7
Enhancement of Apo2L/TRAIL signaling pathway receptors by the activation of Klotho gene with CRISPR/Cas9 in Caco-2 colon cancer cells	7
The “collateral damage” of the war on COVID-19: impact of the pandemic on the care of epithelial ovarian cancer	7
Can the host immune response against SARS-CoV2 also cause an anticancer effect?	7